Obstetrics/Gynecology
RSSArticles
-
Full December 15, 2006 Issue in PDF
-
Pharmacology Watch
In response to several high-profile drug misadventures including the rofecoxib (Vioxx®) withdrawal from the market, the FDA's Center for Drug Evaluation and Research (CDER) asked the Institute of Medicine (IOM) to assess the drug safety system in the United States. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Patients with coronary artery disease who have received intra-coronary, drug-eluding stents (DES) may benefit from longer courses of clopidogrel than is currently standard. -
Full January 1, 2007 Issue in PDF
-
Primary Care Physicians and the Fight Against Lung Cancer
Although it is known that cigarette smoking is the most prevalent risk factor for lung cancer, other risk factors are important. It is notable that 10% of men and 20% of women with lung cancer never smoked, and that nearly half of patients are former smokers. -
Clinical Briefs in Primary Care Volume 12 in PDF
-
Clinical Briefs in Primary Care Volume 12 in PDF
-
Clinical Briefs in Obstetrics & Gynecology Volume 15 in PDF
-
Clinical Briefs in Obstetrics & Gynecology Volume 15 in PDF